ישראל - עברית - Ministry of Health

mediline ltd. - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

ישראל - עברית - Ministry of Health

tree of life pharma ltd. - כלל האוכלוסיה - פלסטרים לחימום שטחי גוף

ישראל - עברית - Ministry of Health

perrigo israel agencies ltd - milnacipran hydrochloride - קפסולות - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.

ישראל - עברית - Ministry of Health

uc-care ltd. - רופא - the uc-care navigotm workstation is intended to be used by physicians in the clinic or hospital for 2-d and 3-d visualization of ultrasound images of the prostate gland. additional software features assist biopsy procedures include patient data management, multi-planar reconstruction, segmentation, image measurement and 3-d image registration. the device is specifically indicated for reconstruction of a 3d rendered surface model of the prostate and to display locations for biopsies that have been selected by the physician, as well as storage and future retrieval of this information. the expected system accuracy is ±5 mm. this includes the accuracy of the prostate surface that is presented to the practitioner over the navigotm workstation screen during 3d model reconstructions and also the accuracy of the biopsy needle trajectory that is presented to the practitioner over the navigotm workstation screen during the biopsy session. all clinical decisions taken regarding the use of the uc-care navigo™ workstation

ישראל - עברית - Ministry of Health

novartis pharma services ag - potassium chloride 600 mg - tablets slow release - potassium chloride - treatment and prevention of hypokalaemia.

ישראל - עברית - Ministry of Health

novartis pharma services ag - potassium chloride 600 mg - tablets slow release - potassium chloride - treatment and prevention of hypokalaemia.

ישראל - עברית - Ministry of Health

neopharm ltd - ranolazine 1000 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.

ישראל - עברית - Ministry of Health

neopharm ltd - ranolazine 1000 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.

ישראל - עברית - Ministry of Health

neopharm ltd - ranolazine 500 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.

ישראל - עברית - Ministry of Health

neopharm ltd - ranolazine 500 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.